MAPK14 and Parkinson disease: Compared with saline treatment, miR-181a–2–3p expression levels were increased and those of EGR1, NOX4, and p–p38 were decreased in PD mice injected with MSC-EV-NC-mimic or MSC-EV-miR-181a–2–3p mimic.